litlas
ログインアカウント作成

Clifford A. Hudis

1991–2025 年に発表

217
論文数
71,291
被引用数
127
h 指数
214
i10 指数

被引用数

Clifford A. Hudis の年別被引用数1971 年: 被引用 2 件1980 年: 被引用 1 件1981 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 7 件1995 年: 被引用 17 件1996 年: 被引用 21 件1997 年: 被引用 37 件1998 年: 被引用 37 件1999 年: 被引用 54 件2000 年: 被引用 70 件2001 年: 被引用 84 件2002 年: 被引用 92 件2003 年: 被引用 164 件2004 年: 被引用 175 件2005 年: 被引用 249 件2006 年: 被引用 270 件2007 年: 被引用 315 件2008 年: 被引用 355 件2009 年: 被引用 391 件2010 年: 被引用 424 件2011 年: 被引用 488 件2012 年: 被引用 495 件2013 年: 被引用 505 件2014 年: 被引用 588 件2015 年: 被引用 730 件2016 年: 被引用 857 件2017 年: 被引用 844 件2018 年: 被引用 804 件2019 年: 被引用 2,455 件2020 年: 被引用 2,665 件2021 年: 被引用 2,451 件2022 年: 被引用 1,775 件2023 年: 被引用 1,192 件2024 年: 被引用 1,660 件2025 年: 被引用 730 件2026 年: 被引用 21 件1972〜1979 年は被引用が無いため表示していません1982〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,974 件、この内訳の 28.9%中国: 引用元論文 2,183 件、この内訳の 7.9%イギリス: 引用元論文 1,707 件、この内訳の 6.2%イタリア: 引用元論文 1,587 件、この内訳の 5.7%ドイツ: 引用元論文 1,228 件、この内訳の 4.4%カナダ: 引用元論文 1,165 件、この内訳の 4.2%フランス: 引用元論文 993 件、この内訳の 3.6%スペイン: 引用元論文 887 件、この内訳の 3.2%オーストラリア: 引用元論文 783 件、この内訳の 2.8%オランダ: 引用元論文 735 件、この内訳の 2.7%スイス: 引用元論文 663 件、この内訳の 2.4%ベルギー: 引用元論文 601 件、この内訳の 2.2%
0%28.9%その他 25.8%

機関

分野

  • Medicine55.2%
  • Biochemistry, Genetics and Molecular Biology35.7%
  • Immunology and Microbiology2%
  • Computer Science1.3%
  • Economics, Econometrics and Finance1%
  • Health Professions0.8%
  • その他4%

トピック

  • Breast Cancer Treatment Studies8.5%
  • HER2/EGFR in Cancer Research5.4%
  • Advanced Breast Cancer Therapies3.9%
  • Cancer Treatment and Pharmacology2.7%
  • Breast Lesions and Carcinomas2.4%
  • Cancer survivorship and care2.4%
  • その他74.7%

共著者

全論文

検索で開く
  1. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

    著者: Ethan Basch, Allison M. Deal, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren J. Rogak, Antonia V. Bennett, Amylou C. Dueck, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Allison Barz Leahy, Paul J. Novotny, M. Fruscione, Jeff A. Sloan, Deborah Schrag - Journal of Clinical Oncology 2015 被引用: 2,655

  2. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    著者: Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Richard D. Gelber, Martine Piccart, Beat Thürlimann, Hans-Jörg Senn, Kathy S. Albain, Fabrice André, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel-Morales, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Alberto Costa, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Paul E. Goss, Jay R. Harris, Daniel F. Hayes, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 被引用: 3,715

  3. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    著者: Pedram Razavi, Matthew T. Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S. Ross, Neil Vasan, Yanyan Cai, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Alexander Penson, Ronglai Shen, Fresia Pareja, Ritika Kundra, Sumit Middha, Michael L. Cheng, Ahmet Zehir, Cyriac Kandoth, Ruchi Patel, Kety Huberman, Lillian M. Smyth, Komal Jhaveri, Shanu Modi, Tiffany A. Traina, Chau T. Dang, Wen Zhang, Britta Weigelt, Bob T. Li, Marc Ladanyi, David M. Hyman, Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 被引用: 1,006

  4. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    著者: Fátima Cardoso, A. Costa, Elżbieta Senkus, Matti Aapro, Fabrice André, Carlos H. Barrios, Jonas Bergh, G.S. Bhattacharyya, Laura Biganzoli, Maria João Cardoso, L. Carey, D. Corneliussen-James, Giuseppe Curigliano, Véronique Dièras, N. El Saghir, Alexandru Eniu, Lesley Fallowfield, D. Fenech, Prudence A. Francis, Karen A. Gelmon, Alessandra Gennari, Nadia Harbeck, Clifford A. Hudis, Bella Kaufman, Ian E. Krop, Musa Mayer, Hanneke Meijer, Shirley Mertz, Shinji Ohno, Olivia Pagani, Efthymios Papadopoulos, Fedro A. Peccatori, Frédérique Penault‐Llorca, Martine Piccart, Jean‐Yves Pierga, Hope S. Rugo, Lillie D. Shockney, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Andrew Tutt, Daniel Vorobiof, Binghe Xu, Larry Norton, Eric P. Winer - Annals of Oncology 2016 被引用: 2,062

  5. Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation

    著者: Neil M. Iyengar, Ayca Gucalp, Andrew J. Dannenberg, Clifford A. Hudis - Journal of Clinical Oncology 2016 被引用: 960

  6. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

    著者: Weiyi Toy, Yang Shen, Helen Won, Bradley Green, Rita A. Sakr, Marie Will, Zhiqiang Li, Kinisha Gala, Sean W. Fanning, Tari A. King, Clifford A. Hudis, David Chen, Tetiana Taran, Gabriel N. Hortobágyi, Geoffrey L. Greene, Michael F. Berger, José Baselga, Sarat Chandarlapaty - Nature Genetics 2013 被引用: 1,259

  7. Trastuzumab — Mechanism of Action and Use in Clinical Practice

    著者: Clifford A. Hudis - New England Journal of Medicine 2007 被引用: 2,578

  8. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    著者: Alan S. Coates, Eric P. Winer, Aron Goldhirsch, Richard D. Gelber, Michael Gnant, Martine Piccart, Beat Thürlimann, H.-J. Senn, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Viviana Galimberti, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Nadia Harbeck, Daniel F. Hayes, Jens Huober, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 被引用: 1,837

  9. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

    著者: Donald A. Berry, Deborah Collyar, Sara M. Tolaney, Elisa Port, Baljit Singh, Lisa A. Carey, Charles Kuzma, Clifford A. Hudis, George Somlo, Constance Cirrincione, Mehra Golshan, William M. Sikov, Olwen Hahn, Jennifer R. Bellon, Eric P. Winer, Timothy Pluard, Charles M. Perou - Journal of Clinical Oncology 2014 被引用: 1,030

  10. MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

    著者: Maura N. Dickler, Sara M. Tolaney, Hope S. Rugo, Javier Cortés, Véronique Dièras, Debra A. Patt, Hans Wildiers, Clifford A. Hudis, Joyce O’Shaughnessy, Esther Zamora, Denise A. Yardley, Martin Frenzel, Andrew Koustenis, José Baselga - Clinical Cancer Research 2017 被引用: 683

  11. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

    著者: Harold J. Burstein, Christina Lacchetti, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson, Karen A. Gelmon, Sharon H. Giordano, Clifford A. Hudis, Alexander J. Solky, Vered Stearns, Eric P. Winer, Jennifer J. Griggs - Journal of Clinical Oncology 2018 被引用: 630

  12. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial

    著者: Sara M. Tolaney, Paolo Tarantino, Noah Graham, Nabihah Tayob, Laia Paré, Guillermo Villacampa, Chau T. Dang, Denise A. Yardley, Beverly Moy, P. Kelly Marcom, Kathy S. Albain, Hope S. Rugo, Matthew J. Ellis, Iuliana Shapira, Antonio C. Wolff, Lisa A. Carey, Romualdo Barroso‐Sousa, Patricia Villagrasa, Michelle K. DeMeo, Molly DiLullo, Jorge Gómez Tejeda Zañudo, Jakob Weiß, Nikhil Wagle, Ann H. Partridge, Adrienne G. Waks, Clifford A. Hudis, Ian E. Krop, Harold J. Burstein, Aleix Prat, Eric P. Winer - The Lancet Oncology 2023 被引用: 165

  13. Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

    著者: Clifford A. Hudis, William E. Barlow, Joseph P. Costantino, Robert J. Gray, Kathleen I. Pritchard, J. W. Chapman, Joseph A. Sparano, Sally Hunsberger, Rebecca A. Enos, Richard D. Gelber, Jo Anne Zujewski - Journal of Clinical Oncology 2007 被引用: 885

  14. Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343

    著者: Kevin S. Hughes, Lauren A. Schnaper, Jennifer R. Bellon, Constance Cirrincione, Donald A. Berry, Beryl McCormick, Hyman B. Muss, Barbara L. Smith, Clifford A. Hudis, Eric P. Winer, William C. Wood - Journal of Clinical Oncology 2013 被引用: 1,301

  15. CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

    著者: Jonathan H. Shepherd, Karla Ballman, Mei-Yin C. Polley, Jordan D. Campbell, Cheng Fan, Sara Selitsky, Aranzazu Fernandez-Martinez, Joel S. Parker, Katherine A. Hoadley, Zhiyuan Hu, Yan Li, Matthew G. Soloway, Patricia A. Spears, Baljit Singh, Sara M. Tolaney, George Somlo, Elisa R. Port, Cynthia Ma, Charles Kuzma, Eleftherios Mamounas, Mehra Golshan, Jennifer R. Bellon, Deborah Collyar, Olwen M. Hahn, Clifford A. Hudis, Eric P. Winer, Ann Partridge, Terry Hyslop, Lisa A. Carey, Charles M. Perou, William M. Sikov - Journal of Clinical Oncology 2022 被引用: 151

  16. Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

    著者: Ayca Gucalp, Sara M. Tolaney, Steven J. Isakoff, James N. Ingle, Minetta C. Liu, Lisa A. Carey, Kimberly Blackwell, Hope S. Rugo, Lisle M. Nabell, Andres Forero, Vered Stearns, Ashley S. Doane, Michael A. Danso, Mary Ellen Moynahan, Lamia F. Momen, Joseph M. Gonzalez, Arooj Akhtar, Dilip D. Giri, Sujata Patil, Kimberly Feigin, Clifford A. Hudis, Tiffany A. Traina - Clinical Cancer Research 2013 被引用: 740

  17. Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience

    著者: Andrew D. Seidman, Clifford A. Hudis, Mary Kathryn Pierri, Steven Shak, Virginia Paton, Mark Ashby, Maureen Murphy, Stanford J. Stewart, Deborah Keefe - Journal of Clinical Oncology 2002 被引用: 1,506

  18. Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

    著者: Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, Nicholas J. Robert, Hyman B. Muss, Julie R. Gralow, Karen A. Gelmon, Timothy J. Whelan, Kathrin Strasser‐Weippl, S. Rubin, Keren Sturtz, Antonio C. Wolff, Eric P. Winer, Clifford A. Hudis, Alison Stopeck, J. Thaddeus Beck, Judith S. Kaur, Kate Whelan, Dongsheng Tu, Wendy R. Parulekar - New England Journal of Medicine 2016 被引用: 648

  19. Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

    著者: Marc L. Citron, Donald A. Berry, Constance Cirrincione, Clifford A. Hudis, Eric P. Winer, William J. Gradishar, Nancy E. Davidson, Silvana Martino, Robert B. Livingston, James N. Ingle, Edith A. Perez, John T. Carpenter, David D. Hurd, James F. Holland, Barbara L. Smith, Carolyn I. Sartor, Eleanor H. Leung, Jeffrey S. Abrams, Richard L. Schilsky, Hyman B. Muss, Larry Norton - Journal of Clinical Oncology 2003 被引用: 1,564

  20. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

    著者: Lowell E. Schnipper, Nancy E. Davidson, Dana S. Wollins, Courtney Tyne, Douglas W. Blayney, Diane Blum, Adam P. Dicker, Patricia A. Ganz, J. Russell Hoverman, Robert M. Langdon, Gary H. Lyman, Neal J. Meropol, Therese M. Mulvey, Lee N. Newcomer, Jeffrey Peppercorn, Blasé N. Polite, Derek Raghavan, Gregory Rossi, Leonard B. Saltz, Deborah Schrag, Thomas J. Smith, Peter Paul Yu, Clifford A. Hudis, Richard L. Schilsky - Journal of Clinical Oncology 2015 被引用: 905

  21. Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

    著者: Sara M. Tolaney, William T. Barry, Chau T. Dang, Denise A. Yardley, Beverly Moy, P. Kelly Marcom, Kathy S. Albain, Hope S. Rugo, Matthew J. Ellis, Iuliana Shapira, Antonio C. Wolff, Lisa A. Carey, Beth Overmoyer, Ann H. Partridge, Hao Guo, Clifford A. Hudis, Ian E. Krop, Harold J. Burstein, Eric P. Winer - New England Journal of Medicine 2015 被引用: 748

  22. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

    著者: Fátima Cardoso, John M.S. Bartlett, Leen Slaets, Carolien H. M. van Deurzen, Elise van Leeuwen-Stok, Peggy L. Porter, Barbro Linderholm, Ingrid Hedenfalk, C.P. Schröder, John W.M. Martens, Jane Bayani, CJ van Asperen, Melissa P. Murray, Clifford A. Hudis, Lavinia P. Middleton, Joanna Vermeij, Kevin Punie, Judith Fraser, Monika Nowaczyk, Isabel T. Rubio, Stefan Aebi, Catherine M. Kelly, Kathryn J. Ruddy, Eric P. Winer, Cecilia Nilsson, Lissandra Dal Lago, Larissa A. Korde, Kim Benstead, Oliver Bögler, Theodora Goulioti, Aleksandra Peric, Saskia Litière, K.C. Aalders, Coralie Poncet, Konstantinos Tryfonidis, Sharon H. Giordano - Annals of Oncology 2017 被引用: 399

  23. A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling

    著者: Heather L. McArthur, Adi Diab, David B. Page, Jianda Yuan, Stephen B. Solomon, Virgilio Sacchini, Christopher Comstock, Jeremy C. Durack, Majid Maybody, Janice S. Sung, Arielle A. Ginsberg, Phillip Wong, Afşar Barlas, Zhiwan Dong, Chunjun Zhao, Brian Blum, Sujata Patil, Deirdre Neville, Elizabeth Comen, Elizabeth A. Morris, Alan Kotin, Edi Brogi, Yuetao Wen, Monica Morrow, Mario E. Lacouture, Padmanee Sharma, James P. Allison, Clifford A. Hudis, Jedd D. Wolchok, Larry Norton - Clinical Cancer Research 2016 被引用: 224

  24. Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

    著者: Pedram Razavi, Maura N. Dickler, Payal D. Shah, Weiyi Toy, David N. Brown, Helen Won, Bob T. Li, Ronglai Shen, Neil Vasan, Shanu Modi, Komal Jhaveri, Betty Ann Caravella, Sujata Patil, Pier Selenica, Stephen Zamora, Aimee Cowan, Elizabeth Comen, Andy Singh, Anne M. Covey, Michael F. Berger, Clifford A. Hudis, Larry Norton, Rebecca J. Nagy, Justin I. Odegaard, Richard B. Lanman, David B. Solit, Mark E. Robson, Mario E. Lacouture, Edi Brogi, Jorge S. Reis‐Filho, Mary Ellen Moynahan, Maurizio Scaltriti, Sarat Chandarlapaty - Nature Cancer 2020 被引用: 162